Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bladder Cancer Chemoradiation Using Intensity Modulated Radiation Therapy

This study has been terminated.
(More advanced treatments superceded study design)
Sponsor:
Information provided by (Responsible Party):
Ottawa Hospital Research Institute
ClinicalTrials.gov Identifier:
NCT00350688
First received: July 7, 2006
Last updated: July 11, 2012
Last verified: July 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2010
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)